Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
In Situ Biologics announced it raised $1.25 Million in an initial filing from an offering of $2.5 Million
PRIVATEAug 10, 2026•about 3 hours ago
Amount Raised
$1.25 Million
Round Type
Seed
OakdaleManufacturingHealthcare
Company Information
Company
InSitu Biologics
Location
3510 Hopkins Place N.
Oakdale, Minnesota, United States
About
InSitu Biologics is an emerging biotech company focused on development of a multi-phase prolonged release drug delivery platform for localized treatment of pain, cancer, and infection. We use disruptive technology to address unmet needs in the pain management and drug delivery markets.
Related People
Suggested for you
1 contact
Verified contactsKevin B., Managing Director
Predictive Intelligence
Strategic
ML-powered predictions for InSitu Biologics's next move
Oakdale